Hamsa Aljumaili

Endocrinology in Oklahoma City, Oklahoma

Practice Details

Address
5401 N Portland Ave Ste 410
Oklahoma City, OK 73112
Geocoded location: 35.5253, -97.5835
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
MD
NPPES Enumeration
Listed with NPPES since 2019
Sole Proprietor
No
Provider Gender (NPPES)
Female
NPPES Record Updated
August 2024

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 48 Endocrinology, Diabetes & Metabolism practices in Oklahoma City carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Hamsa Aljumaili's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 405-945-4700.

GLP-1 access in Oklahoma City, Oklahoma

Adult obesity rate
36.8%
#7 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Oklahoma telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Oklahoma Medicaid, obesity indication

About 36.8% of Oklahoma adults have obesity (BMI 30+), ranking the state #7 of 50 (CDC BRFSS). Our directory currently lists 105 GLP-1-relevant clinics in Oklahoma City. If a cash-pay route makes more sense, compounded semaglutide through Oklahoma telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Oklahoma options on the best Oklahoma GLP-1 providers page, browse every Oklahoma City listing in the Oklahoma City clinic directory, or read the Oklahoma Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Oklahoma City

Other Oklahoma City listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Oklahoma addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Oklahoma telehealth partners:

Featured Partners · Oklahoma City

Featured GLP-1 providers serving Oklahoma City

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Oklahoma City options on the Oklahoma City clinic directory, our Oklahoma City GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Oklahoma City obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Hamsa Aljumaili's specialty taxonomy but not the specific medications it prescribes or its current service menu. Hamsa Aljumaili is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 405-945-4700 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Hamsa Aljumaili's primary specialty on file is Endocrinology.
Hamsa Aljumaili is located at 5401 N Portland Ave Ste 410, Oklahoma City, OK 73112. The phone number listed in the registry is 405-945-4700. Its full record is public in the CMS National Provider registry under NPI 1487117321.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Hamsa Aljumaili is currently accepting new patients. Call the practice at 405-945-4700 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.